Journal
CHINESE MEDICINE
Volume 16, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s13020-021-00531-1
Keywords
Buyang Huanwu Decoction; Calycosin-7-Glucoside; Diabetic nephropathy; Fibrosis; Inflammation; TGF-beta 1; Smad3
Funding
- Areas of Excellence Scheme, Research Grant Council, Hong Kong [AoE/P-705/16]
- Research Grants Council of Hong Kong [GRF 17113416, 17109019]
- HKU Seed Fund for Basic Research [201910159215, 202011159210]
- Health and Medical Research Fund of Hong Kong [17181831]
Ask authors/readers for more resources
The study demonstrated that Buyang Huanwu Decoction (BHD) could effectively improve renal function and alleviate glomerulosclerosis, inflammation, and fibrosis in diabetic nephropathy. The underlying mechanism may involve the inhibition of TGF-beta 1/Smad3 and NF-kappa B signaling pathways.
Background: Buyang Huanwu Decoction (BHD) is a classical Chinese Medicine formula empirically used for diabetic nephropathy (DN). However, its therapeutic efficacies and the underlying mechanisms remain obscure. In our study, we aim to evaluate the renoprotective effect of BHD on a streptozotocin (STZ)-induced diabetic nephropathy mouse model and explore the potential underlying mechanism in mouse mesangial cells (MCs) treated with high glucose in vitro, followed by screening the active compounds in BHD. Methods: Mice were received 50 mg/kg streptozotocin (STZ) or citrate buffer intraperitoneally for 5 consecutive days. BHD was intragastrically administrated for 12 weeks starting from week 4 after the diabetes induction. The quality control and quantitative analysis of BHD were studied by high-performance liquid chromatography (HPLC). Renal function was evaluated by urinary albumin excretion (UAE) using ELISA. The mesangial matrix expansion and renal fibrosis were measured using periodic acid-schiff (PAS) staining and Masson Trichrome staining. Mouse mesangial cells (MCs) were employed to study molecular mechanisms. Results: We found that the impaired renal function in diabetic nephropathy was significantly restored by BHD, as indicated by the decreased UAE without affecting the blood glucose level. Consistently, BHD markedly alleviated STZ-induced diabetic glomerulosclerosis and tubulointerstitial injury as shown by PAS staining, accompanied by a reduction of renal inflammation and fibrosis. Mechanistically, BHD inhibited the activation of TGF-beta 1/Smad3 and NF-kappa B signaling in diabetic nephropathy while suppressing Arkadia expression and restoring renal Smad7. We further found that calycosin-7-glucoside (CG) was one of the active compounds from BHD, which significantly suppressed high glucose-induced inflammation and fibrosis by inhibiting TGF-beta 1/Smad3 and NF-kappa B signaling pathways in mesangial cells. Conclusion: BHD could attenuate renal fibrosis and inflammation in STZ-induced diabetic kidneys via inhibiting TGF-beta 1/Smad3 and NF-kappa B signaling while suppressing the Arkadia and restoring renal Smad7. CG could be one of the active compounds in BHD to suppress renal inflammation and fibrosis in diabetic nephropathy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available